- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Embecta Corp (EMBC)
The Embecta share price today is 3.56, view NASDAQ EMBC stock exchange data. Track the latest Embecta share price with real-time updates on EMBC stock performance including market cap, day range, 52-week range and dividend yield. Access EMBC charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.55
4.06
52 wk Range
3.55
15.55
Unusual trading volume
1/4
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.554.06
52 wk Range
3.5515.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(16.85%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(16.85%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EMBC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
15.00
Upside
+321.35%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
2 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 15.00
(+321.35% Upside)
Embecta Corp Earnings Call Summary for Q2/2026
- Embecta Q2 FY2026 EPS of $0.27 missed estimates by 35.71%; revenue of $221.8M fell short by 5.88%, triggering 44% stock plunge to $5.15.
- U.S. market revenue plummeted 29.4% YoY in adjusted constant currency, driving overall 14.4% revenue decline and GAAP net loss of $4.1M.
- Company revised full-year guidance downward amid competitive pressures in pen needle and syringe markets; initiating cost and organizational review.
- Strategic focus on Owen Mumford acquisition to expand portfolio, brand transition initiatives, and product development to regain market position.
- Despite challenges, stock trades at 4.47 P/E with 6.49% dividend yield; InvestingPro notes 38% free cash flow yield and 'GREAT' financial health score.
Last Updated: 05-05-2026, 06:34 pm
Read Full TranscriptEarnings
Latest Release
05-05-2026
EPS / Forecast
0.27 / 0.42
Revenue / Forecast
221.8M / 235.66M
Compare EMBC to Peers and Sector
Metrics to compare | EMBC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEMBCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 1.9x | 16.0x | −0.5x | |
PEG Ratio | 0.02 | 0.08 | 0.00 | |
Price/Book | −0.3x | 1.3x | 2.6x | |
Price / LTM Sales | 0.2x | 1.8x | 3.2x | |
Upside (Analyst Target) | 223.0% | 44.1% | 48.3% | |
Fair Value Upside | Unlock | 7.0% | 5.6% | Unlock |
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Embecta (EMBC) Share Price Today?
The Embecta share price today is 3.56.
What is the current Embecta (EMBC) share price and day range?
As of 07-05-2026, the Embecta share price is 3.56, with a previous close of 3.90. The share price has ranged from 3.55 to 4.06 today, while the 52-week range spans from 3.55 to 15.55.
What Is the Embecta Market Cap?
As of today, Embecta market cap is 211.21M.
Does Embecta Pay Dividends? What's The Current Dividend Yield?
The Embecta dividend yield is 16.85%.
What Is the Embecta (EMBC) Share Price Target?
The average 12-month share price target for Embecta is 15.00, with a high estimate of 22 and a low estimate of 11. 1 analysts recommend buying, while 1 suggest selling, with an overall rating of Neutral and +321.35% Upside potential.
What Is Embecta's Earnings Per Share (TTM)?
The Embecta EPS (TTM) is 2.36.
When Is the Next Embecta Earnings Date?
Embecta will release its next earnings report on 07-08-2026.
From a Technical Analysis Perspective, Is EMBC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Embecta Trade On?
Embecta is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Embecta?
The stock symbol for Embecta is "EMBC."
How Many Times Has Embecta Stock Split?
Embecta has split 0 times.
How Many Employees Does Embecta Have?
Embecta has 2000 employees.
What Is the EMBC Premarket Price?
EMBC's last pre-market stock price is 4.00. The pre-market share volume is 2,46,750.00, and the stock has changed by 0.10, or 2.56%.
What Is the EMBC After Hours Price?
EMBC's last after hours stock price is 3.60, the stock has changed by 0.04, or 1.12%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.